Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver HealthJin‐Jin Cui, Lu-Lu Wang, Zhigang Luo et al.|Small Structures|2023Cited by 5
Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver HealthJin‐Jin Cui, Lu-Lu Wang, Rui Li et al.|Small Structures|2023Cited by 0